Current Cancer Drug Targets, Volume 12 - Number 7


Editorial: [Hot Topic: New Approaches in the Treatment of Multiple Myeloma: From Target-based Agents to the New Era of microRNAs (Dedicated to the Memory of Prof. Salvatore Venuta)]

, 12(7): 741 - 742

P. Tassone and P. Tagliaferri

DOI: 10.2174/156800912802429328

Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium

, 12(7): 743 - 756

Fortunato Morabito, Anna Grazia Recchia, Carla Mazzone and Massimo Gentile

DOI: 10.2174/156800912802429373

Molecular Targets for the Treatment of Multiple Myeloma

, 12(7): 757 - 767

Marco Rossi, Maria Teresa Di Martino, Eugenio Morelli, Marzia Leotta, Antonietta Rizzo, Anna Grimaldi, Gabriella Misso, Pierfrancesco Tassone and Michele Caraglia

DOI: 10.2174/156800912802429300

Antiangiogenic Therapeutic Approaches in Multiple Myeloma

, 12(7): 768 - 775

Domenico Ribatti, Giuseppe Mangialardi and Angelo Vacca

DOI: 10.2174/156800912802429346

Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma

, 12(7): 776 - 796

Paola Neri and Nizar J. Bahlis

DOI: 10.2174/156800912802429337

Novel Targets and Derived Small Molecule Inhibitors in Multiple Myeloma

, 12(7): 797 - 813

Klaus Podar

DOI: 10.2174/156800912802429319

Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma

, 12(7): 814 - 822

P. Tassone, P. Neri, R. Burger, M. T. Di Martino, E. Leone, N. Amodio, M. Caraglia and P. Tagliaferri

DOI: 10.2174/156800912802429292

MicroRNAs in the Pathobiology of Multiple Myeloma

, 12(7): 823 - 837

Marta Lionetti, Luca Agnelli, Luigia Lombardi, Pierfrancesco Tassone and Antonino Neri

DOI: 10.2174/156800912802429274

Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma

, 12(7): 838 - 846

P. Tagliaferri, M. Rossi, M. T. Di Martino, N. Amodio, E. Leone, A. Gulla, A. Neri and P. Tassone

DOI: 10.2174/156800912802429355

Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells

, 12(7): 847 - 856

K. Koike, Y. Ueda, H. Hase, K. Kitae, Y. Fusamae, S. Masai, T. Inagaki, Y. Saigo, S. Hirasawa, K. Nakajima, I. Ohshio, Y. Makino, N. Konishi, H. Yamamoto and K. Tsujikawa

DOI: 10.2174/156800912802429283

A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma

, 12(7): 857 - 872

Z. Mihaly, Z. Sztupinszki, P. Surowiak and B. Gyorffy

DOI: 10.2174/156800912802429265

A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis

, 12(7): 873 - 898

T. Joyce, E. Oikonomou, V. Kosmidou, E. Makrodouli, I. Bantounas, S. Avlonitis, G. Zografos and A. Pintzas

DOI: 10.2174/156800912802429364

Webmaster Contact:
Copyright © 2018 Bentham Science